Randy Ban - Feb 23, 2024 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Commercial Officer
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Randy Ban
Stock symbol
INSP
Transactions as of
Feb 23, 2024
Transactions value $
-$2,644,813
Form type
4
Date filed
2/27/2024, 08:39 PM
Previous filing
Feb 13, 2024
Next filing
Aug 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $10.6K +11.3K +372.73% $0.94* 14.3K Feb 23, 2024 Direct
transaction INSP Common Stock Options Exercise $39.6K +940 +6.56% $42.15 15.3K Feb 23, 2024 Direct
transaction INSP Common Stock Sale -$2.27M -12.2K -80.15% $185.37 3.03K Feb 23, 2024 Direct F1
transaction INSP Common Stock Options Exercise $129K +3.06K +101.02% $42.15 6.09K Feb 27, 2024 Direct
transaction INSP Common Stock Sale -$557K -3.06K -50.25% $182.01 3.03K Feb 27, 2024 Direct F2
holding INSP Common Stock 167 Feb 23, 2024 By son
holding INSP Common Stock 166 Feb 23, 2024 By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -11.1K -100% $0.00* 0 Feb 23, 2024 Common Stock 11.1K $0.94 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -200 -100% $0.00* 0 Feb 23, 2024 Common Stock 200 $0.94 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -940 -3.76% $0.00 24.1K Feb 23, 2024 Common Stock 940 $42.15 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -3.06K -12.72% $0.00 21K Feb 27, 2024 Common Stock 3.06K $42.15 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.00 to $186.44. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.00 to $182.25. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The option is fully vested and exercisable.